Skip to main navigation menu Skip to main content Skip to site footer

Original Research (Preprint)

Vol. 1 No. 1 (2025): Regular Issue

A longitudinal study result comparing Anxiety and Depression in hospitalized COVID-19 and non-COVID-19 patients in Mongolia

Submitted
June 30, 2025
Published
June 30, 2025

Abstract

 This longitudinal study aimed to compare levels of anxiety and depression between hospitalized patients with COVID-19 and those hospitalized for other conditions in Mongolia. Utilizing a mixed-methods design, 552 patients were assessed, including 339 with COVID-19 and 153 with non-COVID-19 conditions. Mental health was evaluated using the Patient Health Questionnaire-9 (PHQ-9) for depression and the Generalized Anxiety Disorder 7-item scale (GAD-7) for anxiety. Results indicated that 58.4% of the COVID-19 group and 47.7% of the non-COVID-19 group exhibited signs of depression, while 48.9% and 35.9%, respectively, met criteria for anxiety, with significant differences (p=0.024 and p=0.006). Follow-up assessments at three- and twelve-months post-discharge showed higher rates of depression (57.3% at three months) and anxiety (46.9% at three months) in the COVID-19 group compared to their counterparts. Multivariable logistic regression analysis revealed that the COVID-19 group had a 1.5-fold increased risk of depression and a 1.7-fold increased risk of anxiety, even after adjusting for age, sex, marital status, employment, and household conditions. The findings confirm that COVID-19 significantly increases depression and anxiety among hospitalized patients. Notably, both short-term and long-term follow-ups revealed that depression and anxiety were highly prevalent in the COVID-19 group. 

References

  1. Almeria, M., Cejudo, J. C., Deus, J., & Krupinski, J. (2024). Long neurocognitive and neuropsychiatric sequelae in participants with post-covid-19 infection: A longitudinal study. Neurology International, 16(4), 853–868. https://doi.org/10.3390/neurolint16040064
  2. Bellan, M., Soddu, D., Balbo, P. E., Baricich, A., Zeppegno, P., Avanzi, G. C., Baldon, G., Bartolomei, G., Battaglia, M., Battistini, S., Binda, V., Borg, M., Cantaluppi, V., Castello, L. M., Clivati, E., Cisari, C., Costanzo, M., Croce, A., Cuneo, D., … Pirisi, M. (2021). Respiratory and psychophysical sequelae among patients with covid-19 four months after hospital discharge. JAMA Network Open, 4(1), e2036142. https://doi.org/10.1001/jamanetworkopen.2020.36142
  3. Carvalho, S. A., Pinto, H., Carreiras, D., Palmeira, L., Pereira, M., & Trindade, I. A. (2024). One-year predictors of PTSD symptoms, anxiety, and depression in SARS-CoV-2 survivors: Psychological flexibility and major life events as main predictive factors. Frontiers in Psychology, 15, 1378213. https://doi.org/10.3389/fpsyg.2024.1378213
  4. Chevance, A., Gourion, D., Hoertel, N., Llorca, P.-M., Thomas, P., Bocher, R., Moro, M.-R., Laprévote, V., Benyamina, A., Fossati, P., Masson, M., Leaune, E., Leboyer, M., & Gaillard, R. (2020). Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review. L’Encéphale, 46(3), 193–201. https://doi.org/10.1016/j.encep.2020.04.005
  5. Dong, Y., Ritto, A. P., Damiano, R. F., Coli, A. G., Hadade, R., Rocca, C. C. D. A., Serafim, A. D. P., Guedes, B. F., Nitrini, R., Imamura, M., Forlenza, O. V., & Busatto Filho, G. (2024). Memory complaints after COVID-19: A potential indicator of primary cognitive impairment or a correlate of psychiatric symptoms? Translational Psychiatry, 14(1), 455. https://doi.org/10.1038/s41398-024-03154-w
  6. Gad, B. K., Arafa, M. A., Attia, A. F., Farahat, A. H., & Abdou, M. S. (2023). Depression, anxiety, and stress among COVID-19 patients in South Sinai, Egypt: Prevalence and associated predictors. Scientific Reports, 13(1), 19193. https://doi.org/10.1038/s41598-023-45775-z
  7. González-Sanguino, C., Ausín, B., Castellanos, M. Á., Saiz, J., López-Gómez, A., Ugidos, C., & Muñoz, M. (2020). Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain, Behavior, and Immunity, 87, 172–176. https://doi.org/10.1016/j.bbi.2020.05.040
  8. Heesakkers, H., Van Der Hoeven, J. G., Corsten, S., Janssen, I., Ewalds, E., Simons, K. S., Westerhof, B., Rettig, T. C. D., Jacobs, C., Van Santen, S., Slooter, A. J. C., Van Der Woude, M. C. E., Van Den Boogaard, M., & Zegers, M. (2022). Clinical outcomes among patients with 1-year survival following intensive care unit treatment for covid-19. JAMA, 327(6), 559. https://doi.org/10.1001/jama.2022.0040
  9. Hennemann, A.-K., Timmermeister, M., Drick, N., Pink, I., Weissenborn, K., & Dirks, M. (2024). When fatigue and cognitive impairment persist- a neurological follow-up-study in patients with Post-COVID syndrome. Scientific Reports, 14(1), 27083. https://doi.org/10.1038/s41598-024-78496-y
  10. Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  11. Lusida, M. A. P., Salamah, S., Jonatan, M., Wiyogo, I. O., Asyari, C. H., Ali, N. D., Asmara, J., Wahyuningtyas, R. I., Triyono, E. A., Ratnadewi, N. K., Irzaldy, A., & Alkaff, F. F. (2022). Prevalence of and risk factors for depression, anxiety, and stress in non-hospitalized asymptomatic and mild COVID-19 patients in East Java province, Indonesia. PLOS ONE, 17(7), e0270966. https://doi.org/10.1371/journal.pone.0270966
  12. Majoka, M. A., & Schimming, C. (2021). Effect of social determinants of health on cognition and risk of alzheimer disease and related dementias. Clinical Therapeutics, 43(6), 922–929. https://doi.org/10.1016/j.clinthera.2021.05.005
  13. Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2020). Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity, 89, 594–600. https://doi.org/10.1016/j.bbi.2020.07.037
  14. Mehari, E. A., Kidane, R. B., Areki, M. F., Seid, A. M., & Gelaye, A. T. (2023). The magnitude and associated factors of anxiety and depression among non-communicable chronic disease patients during COVID-19 pandemic in a resource-limited setting. Clinical Epidemiology and Global Health, 21, 101274. https://doi.org/10.1016/j.cegh.2023.101274
  15. Németh, R., Sik, D., Zaboretzky, B., & Katona, E. (2024). Depression in times of a pandemic – the impact of COVID-19 on the lay discourses of e-mental health communities. Information, Communication & Society, 27(3), 538–560. https://doi.org/10.1080/1369118X.2023.2222168
  16. Neufeld, K. J., Leoutsakos, J.-M. S., Yan, H., Lin, S., Zabinski, J. S., Dinglas, V. D., Hosey, M. M., Parker, A. M., Hopkins, R. O., & Needham, D. M. (2020). Fatigue symptoms during the first year following ards. Chest, 158(3), 999–1007. https://doi.org/10.1016/j.chest.2020.03.059
  17. Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The gad-7. Archives of Internal Medicine, 166(10), 1092. https://doi.org/10.1001/archinte.166.10.1092
  18. Torales, J., O’Higgins, M., Castaldelli-Maia, J. M., & Ventriglio, A. (2020). The outbreak of COVID-19 coronavirus and its impact on global mental health. International Journal of Social Psychiatry, 66(4), 317–320. https://doi.org/10.1177/0020764020915212
  19. Vergori, A., Del Duca, G., Borrelli, P., Brita, A. C., Pinnetti, C., Mastrorosa, I., Camici, M., Mondi, A., Mazzotta, V., Chinello, P., Mencarini, P., Giancola, M. L., Abdeddaim, A., Girardi, E., & Antinori, A. (2024). Cognitive outcomes and psychological symptoms in an Italian cohort with post-acute COVID-19 condition (Pacc). Heliyon, 10(20), e39431. https://doi.org/10.1016/j.heliyon.2024.e39431
  20. Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., McIntyre, R. S., Choo, F. N., Tran, B., Ho, R., Sharma, V. K., & Ho, C. (2020). A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain, Behavior, and Immunity, 87, 40–48. https://doi.org/10.1016/j.bbi.2020.04.028
  21. Wu, K., Lee, D., Sze, A., Ng, V., Cho, V., Cheng, J., Wong, M., Cheung, S., & Tsang, O. (2022). Posttraumatic stress, anxiety, and depression in covid-19 survivors. East Asian Archives of Psychiatry, 32(1), 5–10. https://doi.org/10.12809/eaap2176